Loading...
OTCMPPJE
Market cap530kUSD
Dec 27, Last price  
0.00USD
1D
-99.00%
1Q
-99.00%
Jan 2017
-99.00%
Name

PPJ Healthcare Enterprises Inc

Chart & Performance

D1W1MN
OTCM:PPJE chart
P/E
7.10
P/S
0.75
EPS
0.00
Div Yield, %
0.00%
Shrs. gr., 5y
-6.40%
Rev. gr., 5y
19.39%
Revenues
711k
-10.06%
01,667,2821,565,2621,011,6440103,000152,000319,059330,882406,880293,076351,890305,501648,716790,556711,039
Net income
75k
-47.06%
-46,422-1,878,568-1,029,399-2,997,584-2,244,076-185,353-133,873-10,877,902-14,902-37,3274,57046,06340,160141,150141,15074,728
CFO
3m
-16.14%
-13,722-295,106-212,807-94,588-467,242002,618,408262,06810,885,19312,158,28012,717,94513,226,56313,846,1543,020,0482,532,470

Profile

PPJ Healthcare Enterprises, Inc., through its subsidiaries, provides automated healthcare reimbursement cycle, online health information digital-systems, and practice information management digital-system software to health care providers and general businesses worldwide. The company offers the Automated Biller, a medical billing system that allows physicians to bill their medical insurance claims at the point of service without data entry, coding, or billing personnel. It also provides billing, specialty medical billing, collection, and workers comp lien collection services for health care providers in the areas of pain management, anesthesia and surgery centers practices, and various specialties of medicine. The company was formerly known as PPJ Enterprise and changed its name to PPJ Healthcare Enterprises, Inc. in October 2014. PPJ Healthcare Enterprises, Inc. was founded in 2000 and is headquartered in Reno, Nevada.
IPO date
May 07, 2004
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
711
-10.06%
791
21.86%
649
112.34%
Cost of revenue
495
514
379
Unusual Expense (Income)
NOPBT
216
277
270
NOPBT Margin
30.39%
35.04%
41.62%
Operating Taxes
(168)
(228)
(237)
Tax Rate
NOPAT
384
505
507
Net income
75
-47.06%
141
0.00%
141
251.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
15,918
15,918
20,332
BB yield
-963.85%
-1,000.00%
-525.00%
Debt
Debt current
2,593
2,671
2,797
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
2,544
2,264
2,150
Cash flow
Cash from operating activities
2,532
3,020
13,846
CAPEX
Cash from investing activities
1,002
1,078
Cash from financing activities
15,954
15,973
20,437
FCF
308
(772)
(3,144)
Balance
Cash
49
407
646
Long term investments
Excess cash
14
367
614
Stockholders' equity
38,609
37,751
10,504
Invested Capital
14,555
14,484
13,179
ROIC
2.64%
3.65%
4.47%
ROCE
1.48%
1.87%
1.96%
EV
Common stock shares outstanding
5,504,836
5,305,836
4,840,836
Price
0.00
0.00%
0.00
-62.50%
0.00
33.33%
Market cap
1,651
3.75%
1,592
-58.90%
3,873
33.33%
EV
9,890
9,551
11,718
EBITDA
216
277
270
EV/EBITDA
45.78
34.48
43.40
Interest
Interest/NOPBT